UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Health‐related quality of life in survivors of advanced melanoma treated with anti‐PD1‐based immune checkpoint inhibitors

Cancer medicine (Malden, MA), 2023-06, Vol.12 (11), p.12861-12873

2023

Volltextzugriff (PDF)

Understanding quality of life issues in patients with advanced melanoma: Phase 1 and 2 in the development of the EORTC advanced melanoma module

European journal of cancer (1990), 2024-08, Vol.207, p.114176, Article 114176

2024

Volltextzugriff (PDF)

The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors

Annals of oncology, 2018-11, Vol.29, p.ix105-ix105

2018

Volltextzugriff (PDF)

Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

European journal of cancer (1990), 2024-03, Vol.200, p.113601-113601, Article 113601

2024

Volltextzugriff (PDF)

Common toxicities associated with immune checkpoint inhibitors and targeted therapy in the treatment of melanoma: A systematic scoping review

Critical reviews in oncology/hematology, 2023-03, Vol.183, p.103919-103919, Article 103919

2023

Volltextzugriff (PDF)

International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire

International journal of radiation oncology, biology, physics, 2023-04, Vol.115 (5), p.1155-1164

2023

Volltextzugriff (PDF)

P39.06 Surviving Metastatic Non-Small Cell Lung Cancer – Experience and Supportive Care Needs of Patients Receiving Novel Therapies

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S468-S468

2021

Volltextzugriff (PDF)

345OThe survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors

Annals of oncology, 2018-11, Vol.29 (suppl_9)

2018

Volltextzugriff (PDF)

Induction monotherapy with sirolimus has selected beneficial effects on glomerular and tubulointersititial injury in nephrotoxic serum nephritis

International journal of nephrology and renovascular disease, 2014-01, Vol.7 (default), p.303-313

2014

Volltextzugriff (PDF)

Phase I of the Development of an EORTC QOL Module for Patients with Advanced Melanoma

QUALITY OF LIFE RESEARCH, 2022, Vol.31, p.S64

2022

Volltextzugriff (PDF)

Which patients with dermatological conditions are admitted via the emergency department?

Australasian journal of dermatology, 2014-11, Vol.55 (4), p.255-259

2014

Volltextzugriff (PDF)

Which Dermatological Conditions Present to an Emergency Department in Australia?

Emergency Medicine International, 2014-01, Vol.2014 (2014), p.84-87

2014

Volltextzugriff (PDF)

In reply to: 'Study key words are inclusion criteria and should be shared for interpretation'

Australasian journal of dermatology, 2015-05, Vol.56 (2), p.139-141

2015

Volltextzugriff (PDF)

Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era

Journal of clinical oncology, 2023-06, Vol.41 (18), p.3304-3310

2023

Volltextzugriff (PDF)

CN9 An exploratory qualitative study to describe the experience of using a question prompt list for patients in early phase clinical trials

Annals of oncology, 2021-09, Vol.32, p.S1259-S1259

2021

Volltextzugriff (PDF)

CN65 Feasibility, acceptability and utility of a pilot nurse-led survivorship program for people with metastatic melanoma

Annals of oncology, 2022-09, Vol.33, p.S1373

2022

Volltextzugriff (PDF)

CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience

Journal of oncology, 2019-01, Vol.2019 (2019), p.1-7

2019

Volltextzugriff (PDF)

A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma

British journal of cancer, 2023-09, Vol.129 (5), p.811-818

2023

Volltextzugriff (PDF)

Phase I trial of the RAF/MEK clamp VS-6766 in combination with everolimus using an intermittent schedule with expansion in NSCLC across multiple KRAS variants

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.9018-9018

2022

Volltextzugriff (PDF)

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS11-05-PS11-05

2021

Volltextzugriff (PDF)

Handbook of Quality of Life in Cancer

1st Edition 2022, 2022

Volltextzugriff (PDF)

Which patients with dermatological conditions are admitted via the emergency department?: Skin conditions admitted via the ED

Australasian journal of dermatology, 2014-11, Vol.55 (4), p.255-259

2014

Volltextzugriff (PDF)

Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling

Nature communications, 2021-03, Vol.12 (1), p.1434-15, Article 1434

2021

Volltextzugriff (PDF)

Queer Transfigurations: Boys Love Media in Asia

1, 2022

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(24)

Publikationsform

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Life Sciences & Biomedicine
(11)
Oncology
(9)
Humans
(7)
Quality Of Life
(5)
Medicin Och Hälsovetenskap
(4)
Melanoma
(4)
Patients
(4)
Female
(3)
Metastasis
(3)
Adult
(2)
Aged
(2)
Cancer
(2)
Cancer And Oncology
(2)
Cancer Och Onkologi
(2)
Care And Treatment
(2)
Diagnosis
(2)
Epidemiology
(2)
Immune Checkpoint Inhibitors
(2)
Immune Checkpoint Inhibitors - Therapeutic Use
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Health‐related quality of life in survivors of advanced melanoma treated with anti‐PD1‐based immune checkpoint inhibitors

Understanding quality of life issues in patients with advanced melanoma: Phase 1 and 2 in the development of the EORTC advanced melanoma module

The survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors

Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

Common toxicities associated with immune checkpoint inhibitors and targeted therapy in the treatment of melanoma: A systematic scoping review

International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire

P39.06 Surviving Metastatic Non-Small Cell Lung Cancer – Experience and Supportive Care Needs of Patients Receiving Novel Therapies

345OThe survivorship experience of patients with metastatic melanoma on long-term immune checkpoint inhibitors

Induction monotherapy with sirolimus has selected beneficial effects on glomerular and tubulointersititial injury in nephrotoxic serum nephritis

Phase I of the Development of an EORTC QOL Module for Patients with Advanced Melanoma

Which patients with dermatological conditions are admitted via the emergency department?

Which Dermatological Conditions Present to an Emergency Department in Australia?

In reply to: 'Study key words are inclusion criteria and should be shared for interpretation'

Evolving Landscape of Metastatic Cancer Survivorship: Reconsidering Clinical Care, Policy, and Research Priorities for the Modern Era

CN9 An exploratory qualitative study to describe the experience of using a question prompt list for patients in early phase clinical trials

CN65 Feasibility, acceptability and utility of a pilot nurse-led survivorship program for people with metastatic melanoma

CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience

A Phase 1/2A trial of idroxioleic acid: first-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma

Phase I trial of the RAF/MEK clamp VS-6766 in combination with everolimus using an intermittent schedule with expansion in NSCLC across multiple KRAS variants

Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer

Handbook of Quality of Life in Cancer

Which patients with dermatological conditions are admitted via the emergency department?: Skin conditions admitted via the ED

Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling

Queer Transfigurations: Boys Love Media in Asia

Suchergebnisse filtern